Osel Devices Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of OSEL Devices Ltd is ₹ 335.5 as of 30 Oct 15:30 . The P/E Ratio of OSEL Devices Ltd changed from 19.5 on March 2025 to 30.8 on March 2026 . This represents a CAGR of 25.68% over 2 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of OSEL Devices Ltd changed from ₹ 390.41 crore on March 2025 to ₹ 899.06 crore on March 2026 . This represents a CAGR of 51.75% over 2 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The Dividend Payout of OSEL Devices Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About OSEL Devices Ltd

Osel Devices Limited was initially incorporated on August 14, 2006 as a Private Limited Company as Innovative Infratech Soultions Private Limited'.
Subsequently, the Company's name changed to Innovative Infratech Solutions Private Limited' and a fresh Certificate of Incorporation dated November 22, 2013 was issued by the Registrar of Companies, Delhi and Haryana.
The name further changed to Osel Devices Private Limited' dated January 16, 2024 by the Registrar of Companies, at Delhi.
Further, Company converted into a Public Limited Company and the name of Company was changed to Osel Devices Limited'.
A fresh Certificate of Incorporation dated May 2, 2024 was issued by the Registrar of Companies, Central Processing Centre. Osel manufactures a comprehensive range of LED display systems and the latest hearing aids, including all major components, at ultra-modern plant.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of OSEL Devices Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, OSEL Devices Ltd or Vanta Bioscience Ltd?

Market cap of OSEL Devices Ltd is 597 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of OSEL Devices Ltd and Vanta Bioscience Ltd?

The stock performance of OSEL Devices Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for OSEL Devices Ltd and Vanta Bioscience Ltd?

As of October 31, 2026, the OSEL Devices Ltd stock price is INR ₹335.5. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.39.

How do dividend payouts of OSEL Devices Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of OSEL Devices Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.